Integrative Health Technologies, Inc.
Other OTCTotal Valuation
Integrative Health Technologies, Inc. carries a market capitalization of 1,626.00, placing it among publicly traded companies globally. Its enterprise value stands at 31.25M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1,626.00 |
| Enterprise Value | 31.25M |
Share Statistics
Integrative Health Technologies, Inc. currently has 40.64M shares outstanding.
| Shares Outstanding | 40.64M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 140.05, and the price-to-book ratio stands at -11.63.
| PE Ratio | N/A |
| PS Ratio | 140.05 |
| PB Ratio | -11.63 |
| P/TBV Ratio | 3.30 |
| P/FCF Ratio | 51.67 |
| P/OCF Ratio | 51.67 |
Enterprise Valuation
The EV/Sales ratio of 137.93 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 245.58 provides insight into valuation relative to core operating earnings.
| EV / Sales | 137.93 |
| EV / EBITDA | 245.58 |
| EV / EBIT | 245.58 |
| EV / FCF | N/A |
Financial Position
Integrative Health Technologies, Inc. maintains a current ratio of 33.98, meaning it holds 34.0x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 33.98 |
| Quick Ratio | 3.13 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -14.06 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.46 |
Stock Price Statistics
Integrative Health Technologies, Inc.'s stock has declined approximately -95% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.
| Beta (5Y) | N/A |
| 52-Week Price Change | -95% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Integrative Health Technologies, Inc. generated 226,592.00 in revenue and converted that into -1.29M in net income, yielding earnings per share of -0.03. EBITDA reached 127,269.00, while operating income came in at 127,269.00.
| Revenue | 226,592.00 |
| Gross Profit | 157,261.00 |
| Operating Income | 127,269.00 |
| Pretax Income | N/A |
| Net Income | -1.29M |
| EBITDA | 127,269.00 |
| EBIT | 127,269.00 |
| Earnings Per Share (EPS) | -0.03 |
Balance Sheet
Total book value stands at -2.73M, with working capital of 7.43M providing operational flexibility.
| Cash & Cash Equivalents | 479,207.00 |
| Total Debt | N/A |
| Net Debt | -10,859.00 |
| Equity (Book Value) | -2.73M |
| Book Value Per Share | -0.07 |
| Working Capital | 7.43M |
Cash Flow
Integrative Health Technologies, Inc. produced 614,171.00 in operating cash flow over the past twelve months.
| Operating Cash Flow | 614,171.00 |
| Capital Expenditures | N/A |
| Free Cash Flow | 614,171.00 |
| FCF Per Share | 0.02 |
Margins
Integrative Health Technologies, Inc. operates with a gross margin of 48.48, reflecting its pricing power and cost economics. The operating margin of 56.17 and net profit margin of -571.20 provide insight into operational efficiency.
| Gross Margin | 48.48 |
| Operating Margin | 56.17 |
| Pretax Margin | N/A |
| Profit Margin | -571.20 |
| EBITDA Margin | 56.17 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 2.68 |
| FCF Yield | 1.94 |
Stock Splits
Integrative Health Technologies, Inc.'s most recent stock split took place on March 26, 2007 with a 200:1 split ratio.
| Last Split Date | 3/26/2007 |
| Split Ratio | 200:1 |
Scores
Integrative Health Technologies, Inc. posts an Altman Z-Score of 85.20, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 85.20 |